U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130162) titled 'Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer' on Aug. 12.
Brief Summary: The present study aims to evaluate the serum level of PIGU protein in patients with breast cancer and its relation with clinical, laboratory and pathological data of the patients.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Intervention:
DIAGNOSTIC_TEST: Measurement of serum PIGU protein concentrations of patients and controls by Enzyme-Linked Immunosorbent Assay (ELISA)
Measurement of serum PIGU protein concentrations of patients and controls by Enzyme-Linked Immunosorbent Assay (ELIS...